Become a logicalchat Member

Latest Post

Good stocks to invest in right now 2024-2025

Stock Analysis: Good Stocks to Invest in Right Now – Snowflake Inc (SNOW) If you're searching for good stocks to invest in right now, Snowflake...

Your story starts here. Sign up and let's connect in ways that truly matter!

HomeMarket AnalysisSensex rises 240 points, Top India Market news - May 2nd

Sensex rises 240 points, Top India Market news – May 2nd

Indian Market 

FII AND DII 

FII BOUGHT 

3304.32 CR
DII BOUGHT

264.27 CR

On April 28, according to preliminary statistics from the National Stock Exchange, foreign institutional investors (FII) acquired shares worth Rs 3,304.32 crore, while domestic institutional investors (DII) bought shares worth Rs 264.27 crore. FII BOUGHT        3304.32 CR DII BOUGHT       264.27 CR

Indian market news 

  1. Market LIVE Updates: Tech Mahindra and ONGC are the top gainers; Nifty rises beyond 18,150; Sensex soars 300 points.
  2. Adani Total Gas Q4 net profit soars 21% to Rs. 98 crore, as revenue increases 10%.
  3. Mold-Tek Technologies increases by 9% as Q4 earnings more than doubles.
  4. After April production and sales numbers showed double-digit growth, NMDC shares increased.
  5. After strong increases in April manganese ore production and sales, MOIL shares increase by 2%.
  6. Varun Beverages’ Q1 earnings increased 69% due to a strong topline and improved margins.
  7. On the strength of strong Q4 profits, Datamatics Global Services reaches a 52-week high.
  8. Angel Broking receives a Rs. 10 lakh punishment from SEBI for breaking the rules.
  9. Asia’s markets decline as risk is reduced ahead of the Fed.
  10. After 30 years, the initial promoter of Axis Bank, SUUTI, retires.
  11. M&M Finance gains 6% in early trading on a strong Q4 report.
  12. Brokers optimistic about Kotak Mahindra Bank following 26% increase in Q4 earnings
  13.  After a US regulator placed a partial clinical hold on the Deuruxolitinib drug, Sun Pharma was among the top Nifty losers.
  14. Satin Creditcare Network increases 12% as Q4 net profit jumps by 60%.
  15. Following receiving ‘Navratna’ status, RVNL increases by 9% in early trade.
  16. After a 32% decline in March quarter profit, UltraTech Cement declines by more than 1%.
  17. Brokerages applaud iDFC First Bank’s highest-ever quarterly earnings as it rises 5%.
  18. Focus on Pharma, auto and banking stocks today; Tata Steel Q4 results

Indian market Today  

SENSEX 242.27  +0.40%  61,354.71
NIFTY50 82.65 +0.46% 18,147.65
BANK NIFTY 118.20 +0.27% 43,352.10

INDIAN MARKET MOVERS  

TOP GAINERS

TOP LOOSER

ONGC

5.40 3.40%

Hero Motocorp

-62.85 2.46%

Tech Mahindra

29.35 2.87%

Sun Pharma

-13.70 -1.39%

HDFC Life

14.50 2.74%

UltraTechCement

-97.60 -1.29%

Hindalco

9.85 2.26%

Britannia

-42.95 -0.94%

Tata Steel

2.35 2.18%

            Bharti Airtel

-9.20 -1.15%

STOCK IN NEWS

Axis Bank: The private sector lender declared that Subrat Mohanty will begin serving as the bank’s “Executive Director” on May 1 after being appointed as such by the board of directors. Mohanty will serve as Executive Director for three years, and his appointment is pending RBI and bank shareholder approval. Biocon: The integrated, multi-product, monoclonal antibodies (mAbs) Drug Substance manufacturing facility (B3) at Biocon Park in Bengaluru has been awarded a Certificate of GMP Compliance by the representative European inspection authority, the Health Products Regulatory Authority (HPRA), Ireland, for an additional product, the biosimilar bevacizumab. B3 facility was granted EU GMP Certification for producing biosimilars last year. UltraTech Cement: For the quarter that concluded in March of FY23, the cement giant’s consolidated earnings fell by 36.1 percent year over year to Rs 1,670.1 crore, in part due to subpar operating margin performance. Operations revenue increased by 18.4% YoY to Rs 18,662.4 crore, while sales volume increased by 14% YoY to 31.7 million tonnes in Q4FY23. Mahindra & Mahindra Financial Services: For the quarter ended March FY23, the non-banking financing firm posted a profit of Rs. 684.12 crore, up 13.86 percent year over year. Comparing the current quarter to the same period last year, net interest income increased by 10.2% to Rs 1,660.2 crore. Disbursement for the quarter climbed by 50% year over year to Rs 13,778 crore, while loan books expanded by 27% to Rs 82770 CR. Kotak Mahindra Bank: The private sector lender outperformed expectations with a standalone profit that increased by 26.3 percent year over year to Rs 3,495.6 crore for the quarter that ended in March FY23. Net interest income increased by 35 percent over the same time period to Rs 6,102.55 crore. Net interest income, non-interest income, and operational profit before provisions all contributed to profitability. RBL Bank: For the quarter that ended in March of FY23, the private sector lender saw a 37 percent year-over-year increase in profit, coming in at Rs 271 crore. This development was fueled by fewer provisions, greater other income, and improved asset quality performance. With credit expanding by 17 percent and deposits increasing by 7 percent, net interest income for the quarter, which totaled Rs 1,211 crore, climbed by 7 percent over the same period last year. IDBI Bank: Despite increased provisions, the bank reported a tremendous 64.1 percent year-over-year increase in standalone profit for the March FY23 quarter of Rs. 1,133.4 crore. This gain was fueled by greater net interest income and a significant improvement in asset quality. Profitability was also increased by strong pre-provision operational profit and non-interest income. For the quarter, net interest income increased by 35.5 percent YoY to Rs 3,280 crore, driven by increases in deposits and credit of 9.6 percent and 18.7 percent, respectively. Rossari Biotech: Operating profit margin helped the chemical manufacturing company’s consolidated earnings for the March FY23 quarter increase by 20.3% year over year to Rs 29 crore. With Rs 406.5 crore, the quarter’s operating revenue decreased 7.4% from the same period last year. Operating-wise, EBITDA increased by 4.3% year over year to Rs 54.6 crore, with a margin increase of 150 basis points to 13.4% for the quarter. RPG Life Sciences: The manufacturer of pharmaceutical goods reported a 37.6% YoY rise in profit at Rs 10.35 crore for the quarter ended March FY23, and a 14.1% YoY gain in sales at Rs 118.5 crore. L&T financing Holdings: For the March FY23 quarter, the non-banking financing company reported a 46.4% year-over-year increase in earnings at Rs 501.08 crore. At Rs 3,216 crore, revenue for the quarter grew over the equivalent period the previous fiscal by 9.1%. Retail book size increased by 35% year over year to Rs 61,053 crore in Q4 FY23, crossing Rs 61,000 crore. Must read book about investing – check here 

Related Post